2014 HEADLINES

- Archives -

Massachusetts Health Council honors Joyce Murphy

Massachusetts Health Council honors Joyce Murphy

Joyce A. Murphy, MPA, executive vice chancellor of Commonwealth Medicine, received the Outstanding Leadership award from the Massachusetts Health Council. Murphy was honored for her work increasing access to health care for high-risk populations.

New ALS-associated gene identified using innovative strategy

New ALS-associated gene identified using innovative strategy

A team of international scientists led by John Landers, PhD, has shown that TUBA4A, the gene encoding the Tubulin Alpha 4A protein, is associated with the familial form of the neurodegenerative disease, amyotrophic lateral sclerosis.   

UMMS celebrates opening of Voyager Therapeutics headquarters

UMMS celebrates opening of Voyager Therapeutics headquarters

UMMS celebrated the opening of a new headquarters for Voyager Therapeutics, a gene therapy company founded by four world leaders in the fields of AAV gene therapy, RNA biology and neuroscience, among them Phillip Zamore, PhD, and Guangping Gao, PhD.  

NIH awards Schiffer $7.9 million to attack drug resistance

NIH awards Schiffer $7.9 million to attack drug resistance

With a new $7.9 million program project grant from the National Institutes of Health, drug resistance expert Celia Schiffer, PhD, hopes to shift the drug development paradigm by putting resistance first in drug design strategies.

Boston Globe: UMMS researcher finds that rare genetic disorder protects against bipolar

Boston Globe: UMMS researcher finds that rare genetic disorder protects against bipolar

Edward Ginns, MD, PhD, has discovered that a rare genetic dwarfism called Ellis van-Creveld (EvC) syndrome protects against bipolar affective disorder, according to a story in the Boston Globe.

Food addiction: The missing piece in the obesity epidemic

Food addiction: The missing piece in the obesity epidemic

Two UMMS events, the Be Mentally Well community lecture series on Oct. 21 and the first-of-its-kind food addiction conference on Oct. 22, will shed light on the latest science about the biology, diagnosis and treatment of food addiction. 

Tuning light to kill deep cancer tumors

Tuning light to kill deep cancer tumors

An international group of scientists led by Gang Han, PhD, has combined a new type of nanoparticle with an FDA-approved photodynamic therapy to effectively kill deep-set cancer cells in vivo with minimal damage to surrounding tissue and fewer side effects than chemotherapy. This promising new treatment strategy could expand the current use of photodynamic therapies to access deep-set cancer tumors.

Szabo inducted into Hungarian Academy of Sciences

Szabo inducted into Hungarian Academy of Sciences

Gyongyi Szabo, MD, PhD, professor of medicine and vice chair for research in the Department of Medicine, was inducted into the Hungarian Academy of Sciences on Wednesday, Oct. 15. 

Blind Spot co-author Mahzarin Banaji to lead campus discussion about unconscious bias

Blind Spot co-author Mahzarin Banaji to lead campus discussion about unconscious bias

In the featured event of the Diversity Campus Read initiative, Mahzarin Banaji, PhD, co-author of The Blind Spot: Hidden Biases of Good People, will describe her work exploring the hidden biases we all carry from a lifetime of exposure to cultural attitudes about human differences. The event takes place on Oct. 28.

Rare genetic disease protects against bipolar disorder

Rare genetic disease protects against bipolar disorder

A team of scientists led by researchers at the UMass Medical School and the University of Miami Miller School of Medicine have identified what is likely a key genetic pathway underlying bipolar disorder, a breakthrough that could lead to better drugs for treating bipolar affective disorder, as well as depression and other related mood disorders. UMMS neurologist and geneticist Edward Ginns, MD, PhD, is lead author on the study. 

Showing 1-10 of 242 items
of 25